In addition to this weekend's American Diabetes Association presentation, it looks like the Resverlogix crew is on the schedule for a poster presentation on July 23rd at next month's Alzheimer's Association International Conference in Chicago. The author list has both Resverlogix scientists as well as members of the BETonMACE and Neurodegenerative Clinical Advisory Boards. No abstract available yet. Jeffrey Cummings of the Neurodegenerative Clinical Advisory Board appears to be listed as the presenter.

"Apabetalone (AN EPIGNETIC BET-INHIBITOR SMALL MOLECULE) and Effects on Cognition in Diabetes Patients with Cardiovascular Disease"

Jeffrey L. Cummings, Jan O Johansson, Ewelina Kulikowski, Norman C. W. Wong, Christopher Halliday, Ken Lebioda, Bengt Winblad, Henrik Zetterberg, Kam Kalantar-Zadeh, Stephen J Nicholls, Greg G Schwartz, Kausik K Ray, and Mike Sweeney.